Skip to main content

Table 1 Summary of recent biomarker studies related to macronutrient foods

From: Dietary biomarkers: advances, limitations and future directions

Food/Dietary componenta

Reference

Biomarkerb (Sample size)

Biological sample

Analytic procedurec

Biomarker classd

Validitye,f (p value)

Reproductivityf (p value)

Sensitivityg

Carbohydrates

Cane Sugar/HFCS

Cook et al. (2009)

13C in blood glucose (5 young adults)

Plasma

GC-IRMS

Short term

R2=0.90 (<0.001)

  
 

Yeung et al. (2010)

13C (186 older adults)

Serum (fasting)

CF-SIRMS

 

r=0.87 (0.01)

  
 

Davy et al. (2011)

13C (60 adults)

Fingerstick

NA-SIMS

Medium term?

r=0.365 (<0.05)

r=0.873 (<0.001)

 

Sugar

Tasevska et al. (2005)

Sucrose & Fructose (12 male adults; 13 adults)

Urine (24 hr)

Enzymatic

Short term

R2= 0.888 (<0.001)

ICC 0.67i

+

 

Kuhnle et al. (2008)

Sucrose (7 adults)

Urine (24 hr)

GC-MS

Short term

   
   

Urine (24 hr)

LC-MS

Short term

   

Whole-Grain Wheat/Rye

Linko-Parvinen et al. (2007)

Enterolactone (ENL) (15 adults)

Plasma (fasting)

TR-FIA

Short term

   
  

Total Alkylreoscinol (AR) concentration

Plasma (fasting)

GC-MS

Short term

R2=0.939 (<0.05)

  
  

Erythrocyte AR

RBC (fasting)

GC-MS

Medium term?

R2=0.854 (<0.05)

  
 

Aurbertin-Leheudre et al. (2008)

Total AR concentration (56 women)

Plasma (fasting)

GC-MS

 

r=0.406 (0.003)

  
  

DHBA

Urine (24 hr)

HPLC

 

r= 0.359 (0.008)

  
  

DHPPA

Urine (24 hr)

HPLC

 

r= 0.402 (0.003)

  
 

Landberg et al. (2008, 2009, 2009)

DHBA, DHPPA (16 adults)

Urine (24 hr)

HPLC

Short term

   
  

Total AR concentration (30 adults; 17 males with prostate cancer)

Plasma (fasting)

GC-MS

Short term

r= 0.58 (<0.001)

ICC 0.90, 0.88i

+

 

Aderson et al. (2011)

Total AR concentration (51 adults)

Plasma (fasting)

GC-MS

Medium term

r=0.53 (<0.001)

r=0.38 (P<0.001)

 

Fats

Total Fat

King et al. (2006)

PUFA, MUFA, SFA

RBC (fasting)

1D-TLC

Long term?

  

+

  

(66 postmenopausal females)

Plasma (fasting)

1D-TLC

   

+

Fatty Acids

Baylin et al. (2002)

PUFA (503 older Costa Ricans)

Adipsoe tissue (fasting)

GLC

 

r=0.58 (<0.001)

  
  

Trans-fatty acids

Adipose tissue (fasting)

GLC

 

r=0.43 (<0.001)

  
 

Poppitt et al. (2005)

SFA, MUFA, PUFA

RBC (fasting)

GC

    
  

(20 male adults)

      
 

Fuhrman et al. (2006)

Oleic acid (204 female adults)

RBC (fasting)

GC

Medium term

r=0.45; 0.47* (<0.001)

  
  

Total PUFA

RBC (fasting)

GC

Medium term

r=0.17h; 0.39* (<0.001)

  
  

Total MUFA

RBC (fasting)

GC

Medium term

r=0.40; 0.48*

  
      

(<0.001)

  
  

Total SFA

RBC (fasting)

GC

 

r=0.14hi; 0.07*hi

  
 

Thiebaut et al. (2009)

SFA, MUFA, PUFA (1,114 female adults)

Serum (fasting)

GC

Long term

r=0.16–0.29 (<0.0001)

  

Essential Fatty Acids (EFA)

Baylin et al. (2005)

Alpha-linolenic acid & Linoleic acid

Adipose tissue

GLC

Long term

r=0.51; 0.52** (<0.05)

  
  

(200 Costa Rican adults)

Blood (fasting)

GLC

Long term

r=0.38; 0.43** (<0.05)

  
   

Plasma (fasting)

GLC

Long term

r=0.39; 0.41** (<0.05)

  
 

Fuhrman et al. (2006)

Linoleic acid (204 female adults)

RBC (fasting)

GC

Medium term

r=0.23; 0.39* (<0.05; <0.001)

  
  

Alpha-linolenic acid

RBC (fasting)

GC

 

r=0.14hi, 0.07*hi

  

EPA, DHA

Kuriki et al. (2003)

EPA (15 male, 79 female Japanese dietitians)

Plasma (fasting)

GC

 

r=0.57; 0.60*** (<0.05; <0.001)

  
  

DHA

Plasma (fasting)

GC

 

r=0.57; 0.30** (<0.05; <0.01)

  
 

Harris et al. (2004)

Omega-3 Index (EPA+DHA) (57 adults)

Plasma (fasting)

GC

Long term

r=0.91(<0.001)

 

+

   

Blood (fasting)

GC

Long term

r=0.91 (<0.001)

 

+

 

O’Brien et al (2009)

15N-EPA (496 adult Eskimos)

Blood

CF-IRMS

 

r=0.47(<0.001)

  
  

15N-DHA

Blood

CF-IRMS

 

r=0.46 (<0.001)

  
 

Nash et al. (2009)

15N-EPA (144 adult Eskimos)

Hair

CF-IRMS

Medium term

r=0.83 (0.001)

  
  

15N-DHA

Hair

CF-IRMS

Medium term

r=0.84 (<0.001)

  

Olive Oil

Micro-Casas et al. (2002)

Tyrosol (7 adults)

Urine (24 hr)

GC-MS

Short term

   
  

Hydroxytyrosol

Urine (24 hr)

GC-MS

Short term

   

Proteins

        

Protein

Bingham (2003)

Urine Nitrogen (8 adults)

Urine (24 hr)

Kjeldahl

Short term

R2=0.99i

  

Animal Protein

Petzke & Lemke (2009)

13C (14 young adult females)

Hair

GC/C/IRMS

Medium term-Long term?

R2=0.44 (0.005)

  
  

15N

Hair

GC/C/IRMS

Medium term- Long term?

R2=0.17h (0.069)

  
 

Cross et al. (2011)

Creatinine (17 male adults)

Urine (24 hr)

Kinetic assay

Short term

Ptrend(<0.0001)

 

+?

  

Taurine

Urine (24 hr)

IEC

Short term?

Ptrend(<0.0001)

 

+?

  

1-methylhistidine

Urine (24 hr)

IEC

Short term?

Ptrend(<0.0001)

 

+

  

3-methylhistidine

Urine (24 hr)

IEC

Short term

Ptrend(<0.0001)

 

+

  1. aHFCS, High fructose corn syrup; EPA, Eicosapentaenoic Acid; DHA, Docosahexaenoic Acid.
  2. bDHBA, 3,5-Dihydroxybenzoic Acid; DHPPA, 3-(3,5-Dihydroxyphenyl)-Propanoic Acid; PUFA, Poly-Unsaturated Fatty Acid; MUFA, Mono-Unsaturated Fatty Acid; SFA, Saturated Fatty Acid; RBC, Red Blood Cell.
  3. cGC-IRMS, gas chromatography isotope ratio mass; CF-SIRMS, Continuous-flow stable isotope ratio mass spectrometry; NA-SIMS, Natural abundance stable isotope mass spectrometry; GC-MS, Gas chromatography-mass spectrometry; LC-MS, Liquid chromatography-mass spectrometry; TR-FIA, Time-resolved fluroimmunoassay; HPLC, High-performance liquid chromatography; 1D-TLC, One-dimensional thin-layer chromatography; GLC, Gas liquid chromatography; GC, Gas chromatography; CF-IRMS, Continuous-flow isotope ratio mass spectrometry; GC/C/IRMS, Gas chromatography/combustion/ isotope ratio mass spectrometry; IEC, Ion-exchange chromatography.
  4. dShort term: hours/days; Medium term: weeks/months; Long term: months/years.
  5. eResults of comparsion of biomarkers to an appropriate dietary assessment method.
  6. fRepresentative values from the literature.
  7. gBiomarker is able to detect changes over time or distinguish high from low consumers; + = sensitivity has been demonstrated.
  8. hCorrelation not significant.
  9. iSignificance not reported.
  10. *Values presented are pre, post menopausal, respectively.
  11. **Values presented are alpha-linolenic, linoleic acid, respectively.
  12. ***Values presented are male, female, respectively.